Bayesian methods for evidence synthesis in cost-effectiveness analysis A. E. AdesMark SculpherGuobing Lu Leading Article 17 September 2012 Pages: 1 - 19
Costs of irritable bowel syndrome in the UK and US Stefanie Maxion-BergemannFrank ThieleckeRito Bergemann Review Article 17 September 2012 Pages: 21 - 37
Incorporating carer effects into economic evaluation Simon DixonMel WalkerSam Salek Original Research Article 17 September 2012 Pages: 43 - 53
Interstitial cystitis Eric Q. WuHoward BirnbaumHaya Taitel Original Research Article 17 September 2012 Pages: 55 - 65
Evaluation of the cost effectiveness of sirolimus versus tacrolimus for immunosuppression following renal transplantation in the UK Phil McEwanSimon DixonCraig J. Currie Original Research Article 17 September 2012 Pages: 67 - 79
Cost effectiveness of bemiparin sodium versus unfractionated heparin and oral anticoagulants in the acute and long-term treatment of deep vein thrombosis Antonio Gómez-OutesEduardo RochaVijay V. Kakkar Original Research Article 17 September 2012 Pages: 81 - 92
Economic evaluation of rivastigmine in patients with Parkinson’s disease dementia Andrew R. WillanRon GoereeGordon Blackhouse Original Research Article 17 September 2012 Pages: 93 - 106